Metabolites associated with abnormal glucose metabolism responding to primary care lifestyle intervention
Ville M. Koistinen, Suvi Manninen, Marjo Tuomainen, Kirsikka Aittola, Elina Järvelä-Reijonen, Tanja Tilles-Tirkkonen, Reija Männikkö, Niina Lintu, Leila Karhunen, Marjukka Kolehmainen, Santtu Mikkonen, Marko Lehtonen, Janne Martikainen, Kaisa Poutanen, Ursula Schwab

TL;DR
This study identifies specific metabolites linked to glucose metabolism that change with lifestyle interventions, offering potential targets for preventing type 2 diabetes.
Contribution
The study introduces a metabolite panel that can distinguish glucose metabolism states and predict lifestyle intervention responses.
Findings
Metabolites like lysophosphatidylcholines with odd-chain fatty acids are associated with improved glucose metabolism.
Twenty-five metabolites showed baseline differences, responded to lifestyle changes, and correlated with glucose metabolism changes.
Amino acids, acylcarnitines, and phospholipids were key metabolic signatures affected by lifestyle interventions.
Abstract
Type 2 diabetes can be prevented by lifestyle intervention. We aimed to identify metabolites that associate with glucose metabolism and respond to lifestyle intervention with evidence-based targets for nutrition and physical activity in individuals at high risk of type 2 diabetes. Standard oral glucose tolerance test (OGTT) was used to categorize 624 participants into those having normal glucose tolerance (NGT), isolated impaired glucose tolerance (IGT), IGT with increased fasting glucose (IGT + IFG), and type 2 diabetes. Plasma LC-MS metabolomics was performed to reveal metabolic signatures. The baseline group differences were analysed with the Kruskal–Wallis test and the effect of intervention with a linear mixed-effects model. Significant differences in the metabolite signature were observed between the baseline groups, particularly in amino acids, acylcarnitines, and phospholipids.…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMetabolomics and Mass Spectrometry Studies · Diabetes, Cardiovascular Risks, and Lipoproteins · Metabolism and Genetic Disorders
